Gerard J. P. van Westen

Orcid: 0000-0003-0717-1817

According to our database1, Gerard J. P. van Westen authored at least 42 papers between 2009 and 2024.

Collaborative distances:
  • Dijkstra number2 of four.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

Online presence:

On csauthors.net:

Bibliography

2024
QSPRpred: a Flexible Open-Source Quantitative Structure-Property Relationship Modelling Tool.
J. Cheminformatics, December, 2024

AlphaFold Meets De Novo Drug Design: Leveraging Structural Protein Information in Multitarget Molecular Generative Models.
J. Chem. Inf. Model., 2024

2023
UnCorrupt SMILES: a novel approach to de novo design.
J. Cheminformatics, December, 2023

DrugEx v3: scaffold-constrained drug design with graph transformer-based reinforcement learning.
J. Cheminformatics, December, 2023

3DDPDs: describing protein dynamics for proteochemometric bioactivity prediction. A case for (mutant) G protein-coupled receptors.
J. Cheminformatics, December, 2023

Collaborative SAR Modeling and Prospective In Vitro Validation of Oxidative Stress Activation in Human HepG2 Cells.
J. Chem. Inf. Model., September, 2023

DrugEx: Deep Learning Models and Tools for Exploration of Drug-Like Chemical Space.
J. Chem. Inf. Model., June, 2023

Large-Scale Modeling of Sparse Protein Kinase Activity Data.
J. Chem. Inf. Model., June, 2023

Proteochemometric Modeling Identifies Chemically Diverse Norepinephrine Transporter Inhibitors.
J. Chem. Inf. Model., March, 2023

Papyrus: a large-scale curated dataset aimed at bioactivity predictions.
J. Cheminformatics, 2023

2022
Identifying Novel Inhibitors for Hepatic Organic Anion Transporting Polypeptides by Machine Learning-Based Virtual Screening.
J. Chem. Inf. Model., 2022

2021
Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.
PLoS Comput. Biol., 2021

GenUI: interactive and extensible open source software platform for de novo molecular generation and cheminformatics.
J. Cheminformatics, 2021

DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology.
J. Cheminformatics, 2021

Computational Approaches for De Novo Drug Design: Past, Present, and Future.
Proceedings of the Artificial Neural Networks - Third Edition., 2021

2020
Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs.
J. Chem. Inf. Model., 2020

Successive Statistical and Structure-Based Modeling to Identify Chemically Novel Kinase Inhibitors.
J. Chem. Inf. Model., 2020

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping.
J. Cheminformatics, 2020

Quantitative prediction of selectivity between the A<sub>1</sub> and A<sub>2A</sub> adenosine receptors.
J. Cheminformatics, 2020

2019
Advances and Challenges in Computational Target Prediction.
J. Chem. Inf. Model., 2019

Drug Discovery Maps, a Machine Learning Model That Visualizes and Predicts Kinome-Inhibitor Interaction Landscapes.
J. Chem. Inf. Model., 2019

A multiple classifier system identifies novel cannabinoid CB2 receptor ligands.
J. Cheminformatics, 2019

An exploration strategy improves the diversity of de novo ligands using deep reinforcement learning: a case for the adenosine A2A receptor.
J. Cheminformatics, 2019

Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling.
J. Cheminformatics, 2019

2018
Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
Briefings Bioinform., 2018

2017
Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling.
J. Chem. Inf. Model., December, 2017

Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.
J. Cheminformatics, 2017

2016
Interacting with GPCRs: Using Interaction Fingerprints for Virtual Screening.
J. Chem. Inf. Model., 2016

Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?
J. Chem. Inf. Model., 2016

Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel.
Bioinform., 2016

2015
Chemically Aware Model Builder (camb): an R package for property and bioactivity modelling of small molecules.
J. Cheminformatics, 2015

Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling.
J. Cheminformatics, 2015

Applications of proteochemometrics - from species extrapolation to cell line sensitivity modelling.
BMC Bioinform., 2015

2014
Chemical, Target, and Bioactive Properties of Allosteric Modulation.
PLoS Comput. Biol., 2014

A document classifier for medicinal chemistry publications trained on the ChEMBL corpus.
J. Cheminformatics, 2014

Proteochemometric modeling in a Bayesian framework.
J. Cheminformatics, 2014

2013
Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data.
PLoS Comput. Biol., 2013

Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets.
J. Cheminformatics, 2013

Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets.
J. Cheminformatics, 2013

2010
Molecular bioactivity extrapolation to novel targets by support vector machines.
J. Cheminformatics, 2010

Predicting the binding type of compounds on the 4 adenosine receptors using proteochemometric models.
J. Cheminformatics, 2010

2009
Chemogenomics: Looking at biology through the lens of chemistry.
Stat. Anal. Data Min., 2009


  Loading...